Chicago Partners Investment Group’s Satsuma Pharmaceuticals, Inc. Common Stock STSA Stock Holding History

Chicago Partners Investment Group’s Portfolio STSA Stock Details STSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-63,863	Closed	-$54.3K	–	696
2022 Q4	$54.3K	Buy	+63,863	New	+$185K	﹤0.01%	629
2021 Q4	–	Sell	-11,150	Closed	-$68K	–	623
2021 Q3	$68K	Buy	+11,150	New	+$59.1K	﹤0.01%	571
2020 Q4	–	Sell	-14,081	Closed	-$52K	–	486
2020 Q3	$52K	Buy	+14,081	New	+$283K	0.01%	402

Other funds holding STSA

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Chicago Partners Investment Group's STSA Position: Q1 2023 in Review

Chicago Partners Investment Group sold out of Satsuma Pharmaceuticals, Inc. Common Stock (STSA) in Q1 2023, closing a stake of 63,863 shares — an estimated $54.3K sold.

Chicago Partners Investment Group first reported a position in STSA in Q3 2020 and held it in 3 quarters. The position peaked at $68K in Q3 2021. 31 funds tracked by Wall St. Rank hold STSA as of Q1 2023.

Chicago Partners Investment Group reported no remaining Satsuma Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Chicago Partners Investment Group sold 63,863 Satsuma Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $54.3K.
Chicago Partners Investment Group first reported a position in Satsuma Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Chicago Partners Investment Group's Satsuma Pharmaceuticals, Inc. Common Stock position peaked at $68K in Q3 2021.
31 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Chicago Partners Investment Group's 13F filing for Q1 2023, filed 26 Apr 2023.